Research

digital therapeutics NHS, dtx uk, nice digital framework

Chronic illness drives demand across the NHS and shapes budgets, workforce planning and service design. People living with multiple long-term conditions account for around half...

bacteriophage therapy, antimicrobial resistance, phage cocktails

Antimicrobial resistance is accelerating across health systems and undermining routine care. Surgical prophylaxis, oncology regimens and neonatal medicine all depend on reliable antibiotics, yet resistant...

stem cell, anthony nolan, donor register

For patients living with blood cancer or a severe blood disorder, a stem cell transplant is often the turning point between decline and recovery. Yet...

gene editing, crispr, somatic editing

Human gene editing sits at a pivotal point in modern medicine. Its capacity to change DNA with precision has moved from conjecture to clinical practice,...

gene therapy

Gene therapy is moving from specialist promise to established practice in 2025. Approvals have broadened across indications, clinical data in Huntington’s disease have shifted expectations...

ibuprofen lysine, acute pain, oral analgesics

For acute pain, time matters. Patients with postoperative dental pain, primary dysmenorrhoea, tension-type headache or migraine want relief that begins quickly and remains reliable. Ibuprofen...

Calciphylaxis

Calciphylaxis, also termed calcific uremic arteriolopathy, is uncommon yet catastrophic. Small and medium dermal arterioles mineralise and thrombose, tissue perfusion collapses, and exquisitely painful lesions...

isopropyl alcohol market

Isopropyl alcohol (IPA) remains a critical solvent and intermediate in various industries, including healthcare, personal care, and electronics. Analyst estimates diverge on headline size, yet...

Frequency density

A single figure can sway a submission or a clinical decision. When continuous data are grouped with unequal intervals, a simple count by bin exaggerates...

Huntington's disease

Huntington’s disease remains without a cure in 2025. Clinical practice focuses on symptom control while a new wave of molecular programmes seeks to slow or...